The present invention refers to pharmaceutical beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and to their oral use in the treatment of inflammatory pathologies of the intestinal tract.Said compositions in microspheres consist of:a) a core consisting of a microsphere of inert material；b) a first intermediate coating comprising beclomethasone dipropionate and at least one physiologically acceptable excipient；c) a second modified-release gastro-resistant coating.The present disclosure also refers to a process for obtaining said compositions.
